Financial Performance: CDBT's revenue, profitability, and growth rates significantly influence its stock price. Strong financial results typically lead to higher investor confidence.

Industry Trends: Developments within the biotechnology industry, including new drug approvals, regulatory changes, and market competition, can affect investor sentiment towards CDBT.

Clinical Trial Results: Positive clinical trial outcomes for CDBT's drug candidates usually result in price increases, while negative results often lead to declines.

Regulatory Approvals: Receiving approval from regulatory bodies like the FDA is a major catalyst for price appreciation. Delays or rejections can negatively impact the stock.

Market Sentiment: General investor mood and overall market conditions (bull or bear markets) influence stock prices. Positive market sentiment can lift CDBT shares.

Company News: Announcements about partnerships, acquisitions, or new product developments can all affect the perceived value of CDBT's stock.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can impact investor risk appetite and the valuation of biotech companies like CDBT.